Leveraging NKG2D Ligands in Immuno-Oncology

Immune checkpoint inhibitors (ICI) revolutionized the field of immuno-oncology and opened new avenues towards the development of novel assets to achieve durable immune control of cancer. Yet, the presence of tumor immune evasion mechanisms represents a challenge for the development of efficient trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuertes, Mercedes Beatriz, Domaica, Carolina Inés, Zwirner, Norberto Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358801/
https://www.ncbi.nlm.nih.gov/pubmed/34394116
http://dx.doi.org/10.3389/fimmu.2021.713158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358801/
https://www.ncbi.nlm.nih.gov/pubmed/34394116
http://dx.doi.org/10.3389/fimmu.2021.713158

Ejemplares similares